• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过扩展清除分类系统(ECCS)整合计算模型以预测植物性植物化学成分的清除途径。

Integration of computational models to predict botanical phytochemical constituent clearance routes by the Extended Clearance Classification System (ECCS).

作者信息

Liu Yitong, Lawless Michael, Roe Amy L, Ferguson Stephen S

机构信息

Division of Toxicology, Office of Chemistry and Toxicology, Office of Laboratory Operations and Applied Science, Human Foods Program, U.S. Food and Drug Administration, Laurel, MD, USA.

Simulations Plus, Inc. Lancaster, California, USA.

出版信息

Toxicol Appl Pharmacol. 2025 Jul;500:117385. doi: 10.1016/j.taap.2025.117385. Epub 2025 May 11.

DOI:10.1016/j.taap.2025.117385
PMID:40360056
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12152754/
Abstract

The Extended Clearance Classification System (ECCS) is a framework that predicts a chemical's predominant rate-determining clearance route: metabolism, hepatic uptake, or renal clearance. The ECCS prediction is based upon molecular weight, ionization state, and membrane permeability, which could be predicted by quantitative structure-activity relationship (QSAR) models. The ECCS also indicates potential chemical interactions via drug-metabolizing enzymes and transporters. This study used the ECCS to evaluate phytochemical constituents and predicted drug-metabolizing enzyme and transporter pathways to understand botanical clearance in humans. First, 82 phytochemical constituents were classified into six ECCS classes based on QSAR-predicted properties. Next, constituents in classes 1A and 2 were further explored as potential substrates for 18 drug-metabolizing enzymes followed by predictions for hepatic clearance, while constituents in classes 3 and 4 leveraged predictions for glomerular filtration and renal transporters. Finally, potential interactions between phytochemical constituents and drugs were discussed. Results showed that more than half of the phytochemical constituents were in ECCS class 2, whose Phase I metabolism were predicted to be predominantly mediated by CYP3A4, CYP2D6, and CYP1A2. Additionally, over 20 % of the phytochemical constituents fell into ECCS class 4, which were predicted to be predominantly cleared in unchanged forms by glomerular filtration and active renal secretion by OAT1/3 or OCT2. Classes 1A and 2 compounds exhibit high interaction potential via CYPs, while classes 3 and 4 compounds have relatively low potential for renal uptake transporter mediated interactions. This study represents a data-driven framework for exploring and contextualizing botanical constituent information to inform safety evaluations.

摘要

扩展清除分类系统(ECCS)是一个预测化学物质主要限速清除途径的框架:代谢、肝脏摄取或肾脏清除。ECCS预测基于分子量、电离状态和膜通透性,这些可通过定量构效关系(QSAR)模型进行预测。ECCS还指出了通过药物代谢酶和转运体产生的潜在化学相互作用。本研究使用ECCS评估植物化学成分,并预测药物代谢酶和转运体途径,以了解人体中的植物清除情况。首先,根据QSAR预测的特性,将82种植物化学成分分为六个ECCS类别。接下来,进一步探究1A类和2类中的成分作为18种药物代谢酶的潜在底物,随后预测肝脏清除情况,而3类和4类中的成分则利用肾小球滤过和肾脏转运体的预测结果。最后,讨论了植物化学成分与药物之间的潜在相互作用。结果表明,超过一半的植物化学成分属于ECCS 2类,预计其I相代谢主要由CYP3A4、CYP2D6和CYP1A2介导。此外,超过20%的植物化学成分属于ECCS 4类,预计主要通过肾小球滤过和OAT1/3或OCT2的主动肾脏分泌以未改变的形式清除。1A类和2类化合物通过细胞色素P450表现出较高的相互作用潜力,而3类和4类化合物通过肾脏摄取转运体介导相互作用的潜力相对较低。本研究代表了一个数据驱动的框架,用于探索植物成分信息并将其置于背景中,以指导安全性评估。

相似文献

1
Integration of computational models to predict botanical phytochemical constituent clearance routes by the Extended Clearance Classification System (ECCS).通过扩展清除分类系统(ECCS)整合计算模型以预测植物性植物化学成分的清除途径。
Toxicol Appl Pharmacol. 2025 Jul;500:117385. doi: 10.1016/j.taap.2025.117385. Epub 2025 May 11.
2
Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS).药物研发中清除机制的预测:扩展清除分类系统(ECCS)。
Pharm Res. 2015 Dec;32(12):3785-802. doi: 10.1007/s11095-015-1749-4. Epub 2015 Jul 9.
3
Projecting ADME Behavior and Drug-Drug Interactions in Early Discovery and Development: Application of the Extended Clearance Classification System.预测早期发现和开发中的 ADME 行为和药物相互作用:扩展清除分类系统的应用。
Pharm Res. 2016 Dec;33(12):3021-3030. doi: 10.1007/s11095-016-2024-z. Epub 2016 Sep 12.
4
Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models.通过计算模型预测植物成分的物理化学和药代动力学性质。
J Appl Toxicol. 2024 Aug;44(8):1236-1245. doi: 10.1002/jat.4617. Epub 2024 Apr 24.
5
Application of the Extended Clearance Classification System (ECCS) in Drug Discovery and Development: Selection of Appropriate In Vitro Tools and Clearance Prediction.扩展清除分类系统 (ECCS) 在药物发现和开发中的应用:合适的体外工具选择和清除预测。
Drug Metab Dispos. 2020 Oct;48(10):849-860. doi: 10.1124/dmd.120.000133. Epub 2020 Aug 1.
6
Organic Anion Transporter 2-Mediated Hepatic Uptake Contributes to the Clearance of High-Permeability-Low-Molecular-Weight Acid and Zwitterion Drugs: Evaluation Using 25 Drugs.有机阴离子转运体 2 介导的肝摄取有助于清除高通透性-低分子量酸性和两性离子药物:25 种药物的评估。
J Pharmacol Exp Ther. 2018 Nov;367(2):322-334. doi: 10.1124/jpet.118.252049. Epub 2018 Aug 22.
7
Cytochrome-P450-Mediated DrugDrug Interactions of Substrate Drugs: Assessing Clinical Risk Based on Molecular Properties and an Extended Clearance Classification System.细胞色素 P450 介导的底物药物的药物药物相互作用:基于分子特性和扩展的清除分类系统评估临床风险。
Mol Pharm. 2020 Aug 3;17(8):3024-3032. doi: 10.1021/acs.molpharmaceut.0c00444. Epub 2020 Jul 7.
8
Plasma Protein Binding Refinement of the Extended Clearance Classification System: Subclasses for Predicting Hepatic Uptake or Renal Clearance for Classes 1B and 3B.扩展清除率分类系统的血浆蛋白结合优化:用于预测1B类和3B类药物肝摄取或肾清除率的亚类
Eur J Drug Metab Pharmacokinet. 2023 Jan;48(1):63-73. doi: 10.1007/s13318-022-00806-4. Epub 2022 Nov 28.
9
Navigating Transporter Sciences in Pharmacokinetics Characterization Using the Extended Clearance Classification System.运用扩展清除分类系统解析药代动力学特征中的转运体科学。
Drug Metab Dispos. 2018 May;46(5):729-739. doi: 10.1124/dmd.117.080044. Epub 2018 Mar 1.
10
Transporter-enzyme interplay and the hepatic drug clearance: what have we learned so far?转运体-酶相互作用与肝脏药物清除率:我们目前了解到了什么?
Expert Opin Drug Metab Toxicol. 2020 May;16(5):387-401. doi: 10.1080/17425255.2020.1749595. Epub 2020 Apr 12.

本文引用的文献

1
Developing a Screening Strategy to Identify Hepatotoxicity and Drug Interaction Potential of Botanicals.制定一种筛选策略以识别植物药的肝毒性和药物相互作用潜力。
J Diet Suppl. 2025;22(1):162-192. doi: 10.1080/19390211.2024.2417679. Epub 2024 Oct 25.
2
Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models.通过计算模型预测植物成分的物理化学和药代动力学性质。
J Appl Toxicol. 2024 Aug;44(8):1236-1245. doi: 10.1002/jat.4617. Epub 2024 Apr 24.
3
Unlocking the Goldenseal Reveals the Complexities of Natural Product-Drug Interactions.揭开白毛茛的奥秘揭示了天然产物与药物相互作用的复杂性。
J Pharmacol Exp Ther. 2023 Dec;387(3):249-251. doi: 10.1124/jpet.123.001863.
4
Study on the difference and correlation between the contents and toxicity of aristolochic acid analogues in Aristolochia plants.研究马兜铃属植物中马兜铃酸类似物的含量和毒性的差异和相关性。
J Ethnopharmacol. 2023 Oct 28;315:116568. doi: 10.1016/j.jep.2023.116568. Epub 2023 May 20.
5
In Vitro-In Vivo Extrapolation and Scaling Factors for Clearance of Human and Preclinical Species with Liver Microsomes and Hepatocytes.在体-体外外推和清除人类和临床前物种的肝微粒体和肝细胞的比例因子。
AAPS J. 2023 Apr 13;25(3):40. doi: 10.1208/s12248-023-00800-x.
6
The Disconnect in Intrinsic Clearance Determined in Human Hepatocytes and Liver Microsomes Results from Divergent Cytochrome P450 Activities.人肝细胞和肝微粒体中内在清除率的差异源于细胞色素 P450 活性的不同。
Drug Metab Dispos. 2023 Jul;51(7):892-901. doi: 10.1124/dmd.123.001323. Epub 2023 Apr 11.
7
Ephedrae herba: A comprehensive review of its traditional uses, phytochemistry, pharmacology, and toxicology.麻黄:传统用途、植物化学、药理学和毒理学的全面综述。
J Ethnopharmacol. 2023 May 10;307:116153. doi: 10.1016/j.jep.2023.116153. Epub 2023 Jan 11.
8
Plasma Protein Binding Refinement of the Extended Clearance Classification System: Subclasses for Predicting Hepatic Uptake or Renal Clearance for Classes 1B and 3B.扩展清除率分类系统的血浆蛋白结合优化:用于预测1B类和3B类药物肝摄取或肾清除率的亚类
Eur J Drug Metab Pharmacokinet. 2023 Jan;48(1):63-73. doi: 10.1007/s13318-022-00806-4. Epub 2022 Nov 28.
9
Drug metabolism and drug transport of the 100 most prescribed oral drugs.100 种最常开出的口服药物的药物代谢和药物转运。
Basic Clin Pharmacol Toxicol. 2022 Nov;131(5):311-324. doi: 10.1111/bcpt.13780. Epub 2022 Aug 24.
10
The Botanical Safety Consortium: A public-private partnership to enhance the botanical safety toolkit.植物药安全性联盟:加强植物药安全性工具包的公私合作伙伴关系。
Regul Toxicol Pharmacol. 2022 Feb;128:105090. doi: 10.1016/j.yrtph.2021.105090. Epub 2021 Dec 1.